Oncology Institute Inc (NASDAQ:TOI) currently has a daily average trading volume of 1.99M but it saw 1233339 shares traded in last market. With a market cap of 53.18M USD, the company’s current market price of $0.70 came rising about 17.63 while comparing to the previous closing price of $0.60. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.45 and as low as $0.13. In the recent trading on the day, stock has struck highest price mark of $0.55 while lowest mark touched by it was $0.7445.
Taking a look at 20-day trading activity of Oncology Institute Inc (TOI) gives us an average price of $0.3560, while its current price level is -71.27% below from 52-week high level whereas it is 461.69% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2636 while that of 200 days or SMA-200 reads an average of $0.4803. A closer look into the stock’s movement over the week reveals that its volatility is standing at 35.92% during that period while stretching the period over a month that decreases to 23.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 89.50 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which resumed the stock as “Buy” in its note to investors issued on February 26, 2024, recommending a price target of $2.50 for it. Jefferies issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, TOI’s stock price is moving 90.27% up while it is 277.98% when we observe its performance for the past one month. Year-to-date it is 127.77% up and over the past year, the stock is showing a downside performance of -67.11%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Oncology Institute Inc’s total number of outstanding shares is 75.56M with 19.56% of that held by the insiders while 47.59% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -43.66% and return on equity (ROE) at -131.66%. Stock’s beta reads 0.26. Stock has a price to book (P/B) ratio of 3.43 while price to sale or P/S ratio amounts to 0.14. Its return on asset (ROA) is -28.92% on average.
